5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.05%
Negative revenue growth while HUH1V.HE stands at 8.13%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-2.86%
Negative gross profit growth while HUH1V.HE is at 10.40%. Joel Greenblatt would examine cost competitiveness or demand decline.
-35.47%
Negative EBIT growth while HUH1V.HE is at 15.52%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-35.47%
Negative operating income growth while HUH1V.HE is at 15.52%. Joel Greenblatt would press for urgent turnaround measures.
-39.09%
Negative net income growth while HUH1V.HE stands at 17.40%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-41.18%
Negative EPS growth while HUH1V.HE is at 15.91%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-41.18%
Negative diluted EPS growth while HUH1V.HE is at 15.91%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
3.54%
Share count expansion well above HUH1V.HE's 0.01%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
3.54%
Diluted share change of 3.54% while HUH1V.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-15.66%
Negative OCF growth while HUH1V.HE is at 361.73%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-54.73%
Negative FCF growth while HUH1V.HE is at 358.21%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-25.54%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 77.83%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-7.94%
Negative 5Y CAGR while HUH1V.HE stands at 36.88%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
20.17%
3Y revenue/share CAGR 1.25-1.5x HUH1V.HE's 16.26%. Bruce Berkowitz might see better product or regional expansions than the competitor.
240.15%
10Y OCF/share CAGR above 1.5x HUH1V.HE's 21.90%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-68.02%
Negative 5Y OCF/share CAGR while HUH1V.HE is at 387.63%. Joel Greenblatt would question the firm’s operational model or cost structure.
247.30%
3Y OCF/share CAGR above 1.5x HUH1V.HE's 107.40%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
134.89%
Net income/share CAGR 1.25-1.5x HUH1V.HE's 106.30%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
105.96%
5Y net income/share CAGR above 1.5x HUH1V.HE's 37.61%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
66.67%
Positive short-term CAGR while HUH1V.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
46.50%
5Y equity/share CAGR at 75-90% of HUH1V.HE's 56.42%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
36.39%
3Y equity/share CAGR above 1.5x HUH1V.HE's 21.38%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
233.14%
5Y dividend/share CAGR above 1.5x HUH1V.HE's 47.20%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
81.82%
3Y dividend/share CAGR above 1.5x HUH1V.HE's 27.19%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-3.07%
Firm’s AR is declining while HUH1V.HE shows 5.95%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.73%
We show growth while HUH1V.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.96%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.70%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
18.05%
Debt growth far above HUH1V.HE's 5.59%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
9.57%
SG&A growth well above HUH1V.HE's 7.56%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.